Breaking News: Leqembi (lecanemab) was approved through the FDA’s accelerated approval pathway, which grants earlier approval to drugs that treat serious conditions and fill an unmet medical need. This is a milestone achievement for people eligible for the treatment, their families and the research community. Read our full statement at the link in our bio.